Canton and Enderbury Islands - Press Releases

  • 7341 Press Releases ยท
  • RSS
Published on Fri 31 Jan 2025 9:21:15 UTC
NORTHBROOK, Ill., Jan. 30, 2025 /PRNewswire/ -- Hilco Global, a leading international financial services company specializing in valuation, monetization, and advisory solutions, announces two key business development appointments. Kyle Murphy has been named Head of Financial Sponsor Coverage & Managing Director for Hilco Global Advisors, and Kate Madine joins as Senior Vice President, Northeast Region for Hilco Global Advisors. These roles underscore Hilco Global's commitment to enhancing client engagement and expanding market reach.
Published on Fri 31 Jan 2025 9:20:24 UTC
PHOENIX, Jan. 30, 2025 /PRNewswire/ -- Prominently featured in The Inner Circle,Rimah A. Sharief, MD, FAAP, is acknowledged as a Pinnacle Lifetime Member for her contributions to Pediatric Endocrinology.
Published on Fri 31 Jan 2025 9:20:17 UTC
CANTON, Ohio, Jan. 30, 2025 /PRNewswire/ -- The nation's most-comprehensive healthsharing ministry got its start 30 years ago this month when a group of five families held the first service of their new church, the Gospel Light Mennonite Church in rural Virginia.
Published on Fri 31 Jan 2025 9:20:12 UTC
Conference Call and Webcast Scheduled for Thursday, February 6
Published on Fri 31 Jan 2025 9:20:05 UTC
ST. PAUL, Minn., Jan. 30, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) will release its fourth quarter fiscal year 2024 financial results on Thursday, February 27, 2025, after the U.S. financial markets close. Following the release, Solventum management will host a webcast to discuss the results and fiscal year 2025 outlook. Other forward-looking and material information may also be discussed during the webcast.
Published on Fri 31 Jan 2025 9:20:01 UTC
BURLINGTON, Mass., Jan. 30, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Dipal Doshi, Chief Executive Officer of Entrada Therapeutics (NASDAQ: TRDA) and a recognized leader in the biotechnology and pharmaceutical industries, has been elected to its Board of Directors at its Annual Meeting of Stockholders held earlier today. Mr. Doshi was nominated for election by the Board, together with nine returning directors, in December 2024.
Published on Fri 31 Jan 2025 9:19:57 UTC
WASHINGTON, Jan. 30, 2025 /PRNewswire/ --Paralyzed Veterans of AmericaChief Executive Officer Carl Blake releases statement following remarks made by President Donald Trump at a press conference addressing yesterday's tragic crash of American Airlines Flight 5342 and an Army Blackhawk helicopter.
Published on Fri 31 Jan 2025 9:19:53 UTC
SECAUCUS, N.J., Jan. 30, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that it has been selected as one of the 2025 World's Most Admired Companies by Fortune magazine, the 11th consecutive year the company has been named to the elite list of globally respected companies.
Published on Fri 31 Jan 2025 9:19:49 UTC
TORONTO and DALLAS, Jan. 30, 2025 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, today announced that Bristol Investor Relations will host an investor webcast Thursday, February 6, 2025 at 2:00 PM ET.
Published on Fri 31 Jan 2025 9:19:46 UTC
AUSTIN, Texas, Jan. 30, 2025 /PRNewswire/ -- Dr. RogerHollis from the University of California, Los Angeles, project scientist from the laboratory of Dr. Donald Kohn, a world leader in developing gene replacement therapies using blood stem cells, has been awarded a $5.8 million translational research award from the California Institute for Regenerative Medicine (CIRM) to further support the development of a hematopoietic stem cell gene therapy (HSC-GT) to treat Angelman syndrome (AS).
Published on Fri 31 Jan 2025 9:19:40 UTC
LOS ANGELES, Jan. 30, 2025 /PRNewswire/ --The DJS Law Groupannounces that it is investigating claims on behalf of investors ofCARGO Therapeutics, Inc. ("CARGO" or "the Company") (NASDAQ: CRGX) for violations of the securities laws.
Published on Fri 31 Jan 2025 9:19:37 UTC
MOBILE, Ala., Jan. 30, 2025 /PRNewswire/ -- AltaPointe Health, a leading provider of behavioral health services in the Mobile community, has reached a significant milestone in its mission to support mental health and crisis intervention. Since opening its Behavioral Health Crisis Center in May 2021, the facility has saved the community more than$50 millionin associated costs.
Published on Fri 31 Jan 2025 9:19:25 UTC
Restore Hyper Wellness Expands Skin Health Offerings with 4 Facials, 4 Chemical Peels, and Retail Home Care Solutions from Jan Marini Skin Research
Published on Fri 31 Jan 2025 9:19:22 UTC
BLINCYTO, ,
Published on Fri 31 Jan 2025 9:19:19 UTC
The MASH treatment landscape is evolving rapidly, driven by a diverse array of therapeutic classes, each with unique mechanisms and potential impacts. The forecast period reveals significant shifts and emerging trends that will shape future market dynamics.
Published on Fri 31 Jan 2025 9:19:16 UTC
CHICAGO, Jan. 30, 2025 /PRNewswire/ -- The National Association for Healthcare Quality(NAHQ) has announced its 2025 board members and has acknowledged those in leadership positions.Patricia Resnik, MJ, MBA, RRT, FACHE, CPHQ, CHC, CHPC, remains in the role of its 2025 president; Nidia Williams, PhD, MBB, CPHQ, FNAHQ, serves as immediate past president; April M. Taylor, MS, MHA, FACHE, CMQ/OE, CLSSBB, CPHQ, CPPS, is president-elect; andCathy Duquette, PhD, MBA, RN, NEA-BC, CPHQ, FNAHQ, is secretary/treasurer.
Published on Fri 31 Jan 2025 9:19:10 UTC
BLINCYTOwurde zustzlich zu einer mehrphasigen konsolidierenden Chemotherapie eingesetzt und senkte das Sterberisiko im Vergleich zu einer Chemotherapie allein erheblich
Published on Fri 31 Jan 2025 9:19:06 UTC
First Drug Approved in New Class of Non-Opioid Pain Medicines; Agency Continues to Take Steps to Support New Approaches for Pain Management
Published on Fri 31 Jan 2025 9:19:04 UTC
JERSEY CITY, N.J., Jan. 30, 2025 /PRNewswire/ -- Celltrion today announced that the U.S. Food and Drug Administration (FDA) has approved AVTOZMA (CT-P47, tocilizumab-anoh) in both an intravenous (IV) and subcutaneous (SC) formulation as a biosimilar to ACTEMRA. AVTOZMA is indicated for the treatment of multiple diseases including rheumatoid arthritis (RA), giant cell arteritis (GCA), polyarticular juvenile idiopathic arthritis (pJIA), systemic juvenile idiopathic arthritis (sJIA) and coronavirus disease (COVID-19).[1]
Published on Fri 31 Jan 2025 9:19:02 UTC
NEW YORK, Jan. 30, 2025 /PRNewswire/ -- Report with the AI impact on market trends - The global genomics marketsize is estimated to grow by USD 5.21 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over3.16% during the forecast period. Rising investments in genomics research and developmentis driving market growth,with a trend towardsadvances in sequencing technologies. However,varying regulations in genomics research and testing poses a challenge. Key market players include 10X Genomics Inc., Abcam plc, Agilent Technologies Inc., Becton Dickinson and Co., BGI Group, Bio Rad Laboratories Inc., Danaher Corp., Eppendorf SE, F. Hoffmann La Roche Ltd., Hamilton Bonaduz AG, Illumina Inc., Myriad Genetics Inc., New England Biolabs Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Promega Corp., QIAGEN NV, Standard BioTools Inc., Thermo Fisher Scientific Inc., and PerkinElmer Inc.
Published on Fri 31 Jan 2025 9:18:57 UTC
NEW YORK, Jan. 31, 2025 /PRNewswire/ -- Report on how AI is redefining market landscape - The global vaccine research marketsize is estimated to grow by USD 21.4 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 10.84% during the forecast period. High prevalence of infectious diseasesis driving market growth,with a trend towardsadoption of ai to speed up r and d of vaccines. However,high cost of vaccine research, development, and manufacturing poses a challenge. Key market players include Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., CanSino Biologics Inc., Creative Biogene, CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Merck and Co. Inc., Moderna Inc., Novavax Inc., Panacea Biotec Ltd., Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., and Takeda Pharmaceutical Co. Ltd..
Published on Fri 31 Jan 2025 9:18:51 UTC
SAN FRANCISCO, Jan. 30, 2025 /PRNewswire/ --Revizto, the industry-leading Integrated Collaboration Platform that streamlines and centralizes project workflows and communication, today announced the final list of confirmed speakers and sessions for RevUP, the company's annual global user conference. RevUP will occur at the Gaylord National Resort & Conference Center in Washington, D.C., Feb. 3-5, 2025.
Published on Fri 31 Jan 2025 9:18:47 UTC
Modern town center environment on more than 200 acres includes new city hall, expansive public realm spaces, and thoughtful commercial development
Published on Fri 31 Jan 2025 9:18:16 UTC
HOUSTON, Jan. 30, 2025 /PRNewswire/ --Nauticus Robotics, Inc. (NASDAQ: KITT), a leading innovator in autonomous subsea robotics and software, has entered into a strategic alliance with Leidos (NYSE: LDOS) to advance subsea autonomy solutions.
Published on Fri 31 Jan 2025 9:18:03 UTC
WASHINGTON, Jan. 30, 2025 /PRNewswire/ -- NASA will hold a media teleconference at 2 p.m. EST on Tuesday,Feb. 4, to share information about the agency's upcoming PUNCH (Polarimeter to Unify the Corona and Heliosphere) mission, which is targeted to launch no earlier than Thursday, Feb. 27.